Norepinephrine induces lipolysis in beta1/beta2/beta3-adrenoceptor knockout mice

Area of Science:

• Adipose tissue metabolism
• Endocrinology
• Molecular pharmacology

Background:

• Catecholamines, including norepinephrine and epinephrine, stimulate adipose tissue metabolism.
• These catecholamines primarily act via three beta-adrenoceptor (beta-AR) subtypes (beta1, beta2, beta3) in adipocytes.

Purpose of the Study:

• To investigate the mechanisms of lipid mobilization in adipocytes from beta1/beta2/beta3-AR triple-knockout (beta-less) mice.
• To identify the receptors responsible for residual lipolytic effects in the absence of known beta-ARs.

Main Methods:

• Measurement of glycerol and nonesterified fatty acids released from isolated adipocytes to assess lipolytic activity.
• Comparison of lipolytic responses to various stimuli (corticotropin, adenylyl cyclase activators, protein kinase A activators, catecholamines, beta-AR agonists) between wild-type and beta-less mice.
• Pharmacological characterization of residual lipolytic pathways using specific antagonists and agonists for various receptor types.

Main Results:

• Basal lipolysis and responses to corticotropin or adenylyl cyclase/protein kinase A activators were similar in wild-type and beta-less mice.
• Lipolytic response to norepinephrine and known beta-AR agonists was significantly blunted in beta-less mice.
• A residual, low-affinity lipolytic effect was observed in beta-less mice with catecholamines and beta3-AR agonists, blocked by beta-AR antagonists, but not mediated by alpha-ARs or other neurotransmitter receptors.

Conclusions:

• The known beta-ARs are not solely responsible for catecholamine-induced lipolysis in adipocytes.
• A residual lipolytic pathway exists in beta-less mice, mediated by an unidentified Gs-protein-coupled receptor with low affinity for catecholamines.
• Further research is needed to identify this novel receptor involved in adipose tissue metabolism.